Daxor corporation to present at the h.c. wainwright bioconnect 2022 virtual conference

Oak ridge, tn, jan. 06, 2022 (globe newswire) -- daxor corporation (nyse: dxr), the global leader in blood volume measurement technology, today announces that ceo and president michael feldschuh will present a corporate overview at the h.c. wainwright bioconnect 2022 virtual conference, which is taking place on january 10 – 13, 2022.
DXR Ratings Summary
DXR Quant Ranking